Senseye, Inc.

About

Senseye, Inc. is a digital health company based in Austin, Texas, focused on developing a non-invasive, AI-driven diagnostic platform for mental health conditions. Founded by CEO David Zakariaie, the company employs around 44 people and generates approximately $7 million in revenue. Senseye utilizes patented computer vision and brain-based methodologies to analyze ocular biomarkers through smartphone cameras, enabling objective diagnostics for conditions such as PTSD, major depressive disorder, generalized anxiety disorder, and addiction. The core product, the Senseye Diagnostic Platform, offers a rapid, smartphone-based assessment of PTSD using digital biomarkers from eye physiology. It establishes baselines, tracks outcomes, and personalizes care. The platform also supports expanded diagnostics for various mental health conditions and provides tools for clinical trials, replacing subjective patient-reported outcomes with objective monitoring. Senseye collaborates with the U.S. Department of Defense and Topcon Healthcare, Inc. to enhance ocular biomarker diagnostics in psychiatry, aiming to improve accessibility for global mental health management.